Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIER: Phenylephrine HCl ER vs IR in Common Cold
NCT03339726Phase 2Terminated
- Sponsor
- Johnson & Johnson
- Start
- Nov 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of phenylephrine in common cold, sponsored by Johnson & Johnson. Started Nov 2017; status: terminated.
02
Drugs
phenylephrine
03
Conditions
common cold
Beyond the preview
Go deeper on NCT03339726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03339726.